RxDoctor Payments Data

Spring McCann, MD

Anesthesiology · du Bois, PANPI 1407002629

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.5% of the total across 51 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Abbott accounts for 82.7% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2021 at $665 and has fallen 80.4% since, to $130 in 2025. Among anesthesiology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,837in general payments, 2019–2025

Across 51 payments — averaging $55.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • GRT US Holding, Inc.$156
  • Medtronic$100
  • Tonix Medicines, Inc.$84
  • Boston Scientific$74
  • Johnson & Johnson$46
  • plus $31 from 2 others

What the payments were for

  • Food & beverage$2,824100%
  • Education$130%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott43$2,346
GRT US Holding, Inc.1$156
Medtronic1$100
Tonix Medicines, Inc.1$84
Boston Scientific1$74
Johnson & Johnson2$46
Si-bone, Inc.1$17
AbbVie1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,837 in reported general payments places this provider in the 95th percentile of 2,015 anesthesiology providers in Pennsylvania.

See all anesthesiology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$41,789
Medicare patients
134
Services billed
460

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen213$3,639
Gabapentin230$1,923
Naloxone Hcl20$1,502
Pregabalin69$1,422
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen43$951
Oxycodone Hcl26$287
Tizanidine Hcl35$234
Tramadol Hcl76$233
Baclofen36$217
Morphine Sulfate ErMorphine Sulfate14$217
Methocarbamol11$127
Acetaminophen-CodeineAcetaminophen With Codeine18$63
Diazepam13$10

Paid to pharmacies, not to this prescriber.

Other anesthesiology in du Bois

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →